Labo Cadu-Crex Initial Hair Loss Women Ampoules 20 pcs

Labo Cadu-Crex Initial Hair Loss Women is a topical anti-hair loss treatment designed for women experiencing initial or incipient physiological hair thinning. This intensive serum utilizes HSSC Transdermic Technology to deliver active ingredients directly to the scalp, helping to reduce shedding and support hair regrowth during the early stages of hair loss.

• HSSC Complex: Contains the Hair Loss Follicular Islands complex with Crescina-derived re-growth actives.
• Transdermic Delivery: Formulated for deep scalp penetration to target follicles effectively.
• Initial Stage Focus: Specifically calibrated for women with non-pathological, early-stage hair loss.
• One-Month Cycle: The pack contains 20 single-dose ampoules, providing a complete 4-week intensive treatment course.

The formula features a lightweight, fast-absorbing liquid texture that applies easily to clean, dry scalp areas. Key ingredients include biotin, taurine, amino acids such as proline and lysine, and Acetyl Tetrapeptide-3, which work together to strengthen weak follicles and improve hair quality. The presence of menthol provides a refreshing sensation upon application.

For optimal results, apply one ampoule daily, five times per week, allowing two days of rest. Each glass vial contains 3.5 ml of serum. This product is part of the Labo Suisse Cadu-Crex line, backed by Swiss Patent CH 711 466. It is not effective on completely atrophied follicles but serves as a targeted intervention for maintaining hair density during the initial phases of thinning.